Tuesday, November 14, 2017

Baxter Issues A Voluntary Nationwide Recall For One Lot of Nexterone Injection Due To Presence Of Particulate Matter - FDA Safety Alerts & Drug Recalls

Baxter International Inc. announced today it is voluntarily recalling one lot of NEXTERONE (amiodarone HCl) 150 mg/100 mL Premixed Injection – distributed between 6/23/2017 and 10/2/2017 in the United States to wholesalers/distributors and healthcare facilities – due to the potential presence of particulate matter. The particulate matter may have entered the solution during the manufacturing process.

from Food and Drug Administration--Recalls/Safety Alerts http://ift.tt/2AGB9YJ
via IFTTT

No comments:

Post a Comment